Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag
- 577 Downloads
Eltrombopag is a new thrombomimetic medication approved for the treatment of immune thrombocytopenia. There are very few reports on the use of eltrombopag in patients with thrombocytopenia associated with sytemic lupus.We present a recent case of a patient with lupus with severe thrombocytopenia refractory to conventional therapy and full recovery with the use of eltrombopag. The present status of the literature with the use of this medication in patients with lupus is reviewed and discussed.
KeywordsEltrombopag Lupus Thrombocytopenia
- 18.Fain O, Ebbo M, Khellaf M et al (2013) Prolonged remission after TPO-receptor agonist discontinuation in adults with chronic ITP. Results of a French Observational Study. Blood 122:327Google Scholar
- 20.Desmond R, Townsley DM, Dumitriu B, et al (2014) Eltrombopag restores tri-lineage hematopoiesis in refractory severe aplastic anemia which can be sustained on discontinuation of drug. Blood 123:1818Google Scholar